Inventor · disambiguated record
Naveen Bejugam
Also filed as: BEJUGAM NAVEEN
3 granted patents·5 pending applications·17 citations·filing 2013–2024
65Inventor score
Top patents by PatentIndex Score
8 records- 0187US10493035B2Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Dec 3, 2019·15 cites·9 claims
- 0274US2024423920A1Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0372US11944612B2Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·0 cites·23 claims
- 0467US9295708B2Modified release formulations for oprozomibONYX THERAPEUTICS INC·Filed 2013·Granted Mar 29, 2016·2 cites·6 claims
- 0565US2022110928A1Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0662US2021267956A1Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0759US2021283061A1Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0837US2016213610A1Modified release formulations for oprozomibONYX THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Naveen Bejugam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →